The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and ...
The companies were two years into a four-year, $400 million agreement aimed at developing and marketing gene therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback